NCT07855107

Brief Summary

Pilonidal sinus is a chronic infection of the sacrococcygeal skin that mainly affects young adults. Traditional surgery leaves large wounds requiring weeks of daily dressing changes away from home. Video-Assisted Ablation of Pilonidal Sinus (VAAPS) is a minimally invasive procedure that leaves only a 7-mm wound, but it requires daily saline flushing of the sinus tract and regular follow-up at the operating center. At Peking University People's Hospital, over 60% of VAAPS patients travel from other provinces and cannot return for standardized daily wound care. To address this, we developed a loose glove-edge seton technique: two rubber strips cut from surgical glove edges are loosely tied around the sinus openings during surgery to keep them patent, allowing normal dressing changes at home without flushing. The first strip is removed at 1 week and the second at 3 weeks postoperatively. This is a single-center prospective observational study of 50 out-of-town patients undergoing VAAPS with this seton technique. We will collect pain scores, time off work, wound healing time, complications, and recurrence over 3 years to assess whether self-care after VAAPS with loose seton is safe, effective, and feasible for patients who cannot return to the operating center for routine care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
64mo left

Started Sep 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Sep 2026Dec 2031

Study Start

First participant enrolled

September 1, 2026

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
4.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2031

Last Updated

October 2, 2026

Status Verified

September 1, 2026

Enrollment Period

1.1 years

First QC Date

September 28, 2026

Last Update Submit

September 28, 2026

Conditions

Keywords

VAAPSPilonidal Sinus

Outcome Measures

Primary Outcomes (3)

  • Time off work after surgery

    Number of days from the date of surgery until the patient returns to normal work or study. Recovery to work is defined as daily activities without significant limitation: no pain at rest or with activity, no pain while walking or sitting, and self-dressing changes no more than twice per day. This measures the primary short-term functional outcome of postoperative self-care after VAAPS combined with loose seton drainage.

    From surgery date until return to normal work or study(assessed at postoperative day 1, weeks 1, 2, 4, 6).

  • Time to complete wound healing after surgery

    Number of days from the date of surgery until the surgical wound is completely epithelialized with no discharge, as assessed by a trained surgeon at follow-up visits. Delayed healing is defined as incomplete healing beyond 6 weeks postoperatively. This measures whether the loose seton technique achieves adequate wound healing in patients performing self-care or local dressing changes without standardized flushing at the operating center.

    From surgery date until complete wound epithelialization (assessed at postoperative weeks 1, 2, 4, 6, and months 3, 6).

  • Postoperative pain score (VAS) after surgery

    Pain assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Patients rate their pain at multiple postoperative time points. Repeated-measures analysis describes the pain trajectory over the early postoperative period. This measures whether the loose seton technique and minimally invasive VAAPS produce tolerable pain during self-care at home.

    Postoperative 6 hours, day 1, week 1, week 2, week 4, and week 6

Secondary Outcomes (3)

  • Recurrence rate

    Postoperative months 3, 6, 12, and 36 (1-year and 3-year recurrence rates reported)

  • Patient Satisfaction Score (PSS)

    Postoperative months 3 and 12

  • Cosmetic outcome assessed by Wound Evaluation Scale

    Postoperative month 6 and 12

Study Arms (1)

VAAPS with Loose Seton Drainage

EXPERIMENTAL

All enrolled participants receive the same intervention: video-assisted ablation of pilonidal sinus (VAAPS) with intraoperative placement of two loose glove-edge seton strips for postoperative drainage.

Procedure: VAAPS with Loose Seton Drainage

Interventions

Video-assisted ablation of pilonidal sinus (VAAPS) is performed through the external sinus opening using a sinusoscope to identify side tracts, remove hair, and ablate the tract wall under direct vision, leaving a wound approximately 5 mm wide. At the completion of the procedure, two thin strips cut from sterile surgical glove edges are loosely looped around the upper and lower sinus openings and secured to the surrounding skin to maintain tract patency. No postoperative saline flushing is required. Patients perform routine dressing changes at a local clinic or at home. The first seton strip is removed at approximately 1 week postoperatively, and the second strip is removed at approximately 3 weeks. This loose seton technique prevents premature wound closure and fluid accumulation while allowing granulation tissue to grow from the tract base.

VAAPS with Loose Seton Drainage

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Clinically diagnosed sacrococcygeal pilonidal sinus by physical examination and pelvic MRI
  • Surgical indication for VAAPS procedure
  • Unable to attend long-term postoperative wound care at the operating center (i.e., out-of-town patients who will return to their local residence for postoperative recovery)
  • American Society of Anesthesiologists (ASA) physical status class I or II
  • Able to understand and provide written informed consent
  • Sufficient clinical records and ability to complete postoperative follow-up

You may not qualify if:

  • Presence of an open sacrococcygeal wound or unhealed wound after incision and drainage that prevent VAAPS surgery.
  • Severe cardiac, pulmonary, hepatic, renal, or other major organ dysfunction, or uncontrolled severe comorbidities
  • Coagulation disorder or ongoing anticoagulation therapy
  • Active infection, immunodeficiency disease, or autoimmune disease
  • Pregnant or breastfeeding women
  • Unable to comply with postoperative follow-up or unable to provide informed consent
  • Other conditions precluding tolerance to general anesthesia or prone positioning

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University People's Hospital

Beijing, Beijing Municipality, 100044, China

RECRUITING

Related Publications (13)

  • Milone M, Di Minno MN, Bianco P, Coretti G, Musella M, Milone F. Pilonidal sinus surgery: could we predict postoperative complications? Int Wound J. 2016 Jun;13(3):349-53. doi: 10.1111/iwj.12310. Epub 2014 Jun 3.

  • Doll D. 5- and 10-year recurrence rate is the new gold standard in pilonidal sinus surgery benchmarking. Med Princ Pract. 2010;19(3):216-7. doi: 10.1159/000285292. Epub 2010 Mar 29. No abstract available.

  • Meinero P, Gasloli G, Giani F, et al. Endoscopic pilonidal sinus treatment: a multicentric prospective study. Tech Coloproctol. 2016;20(11):747-752.

    RESULT
  • Sekhon Inderjit Singh HK, Meinero P, Campanile FC, Quddus A, Rajaganeshan R, Warusavitarne J, Dotlacil V, Bhargava A, Giordano P, Pini Prato A, Shatkar V, Jalali P, Halahakoon VC, Gallo G, Milone M, Mantoo S, Leo CA, Esposito C, Farghaly M, Arulampalam T, Pawa N. The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI). Tech Coloproctol. 2025 Jul 30;29(1):155. doi: 10.1007/s10151-025-03191-7.

  • Milone M, Velotti N, Manigrasso M, Vertaldi S, Di Lauro K, De Simone G, Cirillo V, Maione F, Gennarelli N, Sosa Fernandez LM, De Palma GD. Long-term results of a randomized clinical trial comparing endoscopic versus conventional treatment of pilonidal sinus. Int J Surg. 2020 Feb;74:81-85. doi: 10.1016/j.ijsu.2019.12.033. Epub 2020 Jan 9.

  • Milone M, Fernandez LM, Musella M, Milone F. Safety and Efficacy of Minimally Invasive Video-Assisted Ablation of Pilonidal Sinus: A Randomized Clinical Trial. JAMA Surg. 2016 Jun 1;151(6):547-53. doi: 10.1001/jamasurg.2015.5233.

  • Milone M, Musella M, Di Spiezio Sardo A, Bifulco G, Salvatore G, Sosa Fernandez LM, Bianco P, Zizolfi B, Nappi C, Milone F. Video-assisted ablation of pilonidal sinus: a new minimally invasive treatment--a pilot study. Surgery. 2014 Mar;155(3):562-6. doi: 10.1016/j.surg.2013.08.021. Epub 2013 Oct 25.

  • Al-Khamis A, McCallum I, King PM, Bruce J. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD006213. doi: 10.1002/14651858.CD006213.pub3.

  • Steele SR, Perry WB, Mills S, Buie WD; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of pilonidal disease. Dis Colon Rectum. 2013 Sep;56(9):1021-7. doi: 10.1097/DCR.0b013e31829d2616. No abstract available.

  • Enriquez-Navascues JM, Emparanza JI, Alkorta M, Placer C. Meta-analysis of randomized controlled trials comparing different techniques with primary closure for chronic pilonidal sinus. Tech Coloproctol. 2014 Oct;18(10):863-72. doi: 10.1007/s10151-014-1149-5. Epub 2014 Apr 30.

  • Allen-Mersh TG. Pilonidal sinus: finding the right track for treatment. Br J Surg. 1990 Feb;77(2):123-32. doi: 10.1002/bjs.1800770203.

  • Sondenaa K, Andersen E, Nesvik I, Soreide JA. Patient characteristics and symptoms in chronic pilonidal sinus disease. Int J Colorectal Dis. 1995;10(1):39-42. doi: 10.1007/BF00337585.

  • McCallum IJ, King PM, Bruce J. Healing by primary closure versus open healing after surgery for pilonidal sinus: systematic review and meta-analysis. BMJ. 2008 Apr 19;336(7649):868-71. doi: 10.1136/bmj.39517.808160.BE. Epub 2008 Apr 7.

MeSH Terms

Conditions

Pilonidal Sinus

Condition Hierarchy (Ancestors)

CystsNeoplasms

Study Officials

  • Bozhi Hu, M.D.

    Peking University People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All enrolled participants receive the same intervention: video-assisted ablation of pilonidal sinus (VAAPS) with intraoperative placement of two loose glove-edge seton strips for postoperative drainage. There is no parallel control arm, randomization, or blinded treatment assignment. Outcome data are collected prospectively at predefined postoperative time points (day 1, weeks 1/2/4/6, months 3/6/12, and 36) to describe wound healing, pain, time off work, and recurrence in this patient population.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

September 28, 2026

First Posted

October 2, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

December 31, 2031

Last Updated

October 2, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

This is a single-center observational study with a relatively small sample size (approximately 50 participants). The informed consent form approved by the institutional ethics committee does not include provisions for sharing individual participant data with external researchers. Additionally, all participants are Chinese patients, and their clinical and follow-up data are stored within the hospital's secure electronic medical record system under Chinese data protection regulations, which restrict cross-border data transfer. De-identified aggregate data and study results will be published in peer-reviewed journals, but individual participant data will not be shared publicly or made available to external researchers.

Locations